Novavax, Inc. (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.91 --0%
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue
- Cruise industry faces yield pressure amid geopolitical concerns
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
